Position in VERU
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,210
-$4,210 QoQ
Shares Held
1,000
-66.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chung Wu Investment Group, LLC holds $892,086 across 11 Biotechnology names. VERU ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PVLA |
Palvella Therapeutics, Inc.
|
2,300 | $286,695 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
4,200 | $206,472 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,300 | $193,016 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
2,000 | $76,600 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
2,000 | $36,260 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
3,410 | $30,553 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
|
2,000 | $23,860 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30 | $23,179 |
All Filings in VERU
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,210 | 1,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,420 | 3,000 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||